Pepdexpepdex
Stack
โ„– 062

Pramlintide (Symlin)

A mealtime injection that curbs appetite and steadies blood sugar in diabetics. A synthetic analog of amylin (the satiety hormone co-secreted with insulin), FDA-approved in 2005 as a mealtime adjunct in type 1 and type 2 diabetes, and the clinical predecessor to Cagrilintide.

Fat Loss
Evidence: Strong

Pramlintide (Symlin): A mealtime injection that curbs appetite and steadies blood sugar in diabetics. A synthetic analog of amylin (the satiety hormone co-secreted with insulin), FDA-approved in 2005 as a mealtime adjunct in type 1 and type 2 diabetes, and the clinical predecessor to Cagrilintide. Pramlintide (sold as Symlin) is the synthetic copy of amylin, a satiety hormone your pancreas releases alongside insulin.

FDA โ“˜
Approved
WADA
Not banned
Typical dose
T1D: start 15 mcg pre-meal
Half-life โ“˜
~50 minutes
Route โ“˜
Subcutaneous, before meals
Schedule
Pre-meal injection (multiple times daily)
In plain English

Pramlintide (sold as Symlin) is the synthetic copy of amylin, a satiety hormone your pancreas releases alongside insulin. FDA-approved as a mealtime injection for diabetes. It's the predecessor to Cagrilintide, just shorter-acting and used differently.

Status & legalityWhat do these mean? โ†’
Natty? โ“˜
Not natty
FDA โ“˜
Approved

Approved as Symlin (2005) as adjunct to mealtime insulin in T1D and T2D.

Compounding โ“˜
Approved drug

FDA-approved drug products containing this substance are available. Compounded versions are not FDA-approved.

WADA โ“˜
Not listed
Prescribed โ“˜

Yes, endocrinology providers prescribe in insulin-using diabetes contexts.

Who it's for

  • โ†’T1D or T2D patients struggling with post-meal glucose spikes
  • โ†’Mealtime-insulin users wanting better satiety
  • โ†’Educational reference for amylin pathway

What to expect

  1. Week 1

    Post-meal glucose excursions reduce. Satiety improves.

  2. Week 4

    Insulin requirements often drop 30-50%.

  3. Week 8

    Stable adjunct effect.

Looking at Pramlintide (Symlin)? Your next 3 steps

  1. 1Work out your syringe units

    Vial size + BAC water turns into the exact units to draw for Pramlintide (Symlin).

    Open calculator โ†’
  2. 2See what to stack & monitor

    The companion supplements and the bloodwork worth tracking on this kind of protocol.

    Bloodwork guide โ†’
  3. 3Save it & ask the Coach

    A free account gets you Coach questions every day, free; membership saves your stack and makes the Coach stack-aware.

    Create free account โ†’

How it works (mechanism)

Synthetic amylin analog with three proline substitutions to prevent the aggregation that limits native amylin's drug suitability. Slows gastric emptying and reduces post-meal glucagon.

Dosing protocol

Members only

Stacks well with

Members only

Side effects

01Severe hypoglycemia (when paired with insulin without dose adjustment, boxed warning)
02Nausea, vomiting
03Anorexia
04Headache

When NOT to use

  • โš Hypoglycemia unawareness
  • โš Gastroparesis
  • โš A1C > 9%
  • โš Pregnancy / nursing

Bloodwork to monitor

  • โ€ข A1C
  • โ€ข Glucose monitoring
  • โ€ข Fasting insulin if on insulin therapy

Common mistakes

  • โ€ข Not reducing mealtime insulin by 50% on first dose (causes severe hypoglycemia)
  • โ€ข Using it for non-diabetic weight loss (off-label, less effective than Cagrilintide)
  • โ€ข Skipping the pre-meal timing

What it actually is

Pramlintide, sold as Symlin, is a synthetic version of amylin, the hormone your pancreas releases alongside insulin at every meal. FDA approved it in 2005 as a mealtime add-on for people with type 1 or type 2 diabetes who use insulin. It carries a boxed warning for severe hypoglycaemia. It is the clinical ancestor of cagrilintide, and the difference between them is duration: pramlintide is dosed before every meal, cagrilintide once a week.

In type 1 diabetes the cells that make insulin also make amylin, so when they are destroyed both hormones are lost โ€” insulin replacement alone leaves half the mealtime signal missing. Amylin slows gastric emptying, suppresses the post-meal glucagon rise, and signals fullness through the brainstem. Pramlintide restores that half. The reason for the boxed warning follows directly: adding it to an unchanged insulin dose means the same insulin now acts on food arriving more slowly, and blood sugar falls too far.

Forms, and which is which

Symlin pen (pharmacy)The approved indication

Pre-meal subcutaneous injection, titrated, and it must be given as a separate injection from insulin rather than mixed in the same syringe.

Verdict: The only form, and the separate-injection rule matters.

CagrilintideThe weekly successor

A long-acting amylin analog in development for weight management, with phase 3 data as part of CagriSema.

Verdict: The same pathway without the mealtime dosing burden.

Off-label use for weight lossNot an approved use

The appetite effect is real, but the dosing burden is several injections a day and the hypoglycaemia risk is designed around insulin users.

Verdict: A poor fit for the purpose people reach for it.

Oral amylin analogsDoes not exist as an approved product

No approved oral form.

Verdict: No approved oral form exists.

What it is claimed to do, graded

Improves post-meal glucose control in insulin-using diabetesStrong

The approved indication, supported by 67 indexed randomised-trial records for the molecule.

Reduces mealtime insulin requirementsStrong

Consistently shown, and it is why the insulin dose must be cut when starting rather than after.

Produces modest weight lossModerate

Real and consistent in the trials, and modest โ€” this is not a weight-loss drug, it is a glucose drug that also reduces appetite.

Suitable for weight loss in people without diabetesNone shown

Not an approved use, not what the trials studied, and the pre-meal dosing schedule makes it an impractical choice against the weekly alternatives.

Grades describe how much human evidence exists for that specific claim, not whether it will work for you or whether it is safe.

Pros and cons

Pros
  • โ€ข Approved since 2005 with a large randomised evidence base
  • โ€ข Restores a hormone that is genuinely missing in type 1 diabetes, rather than adding a new signal
  • โ€ข Improves post-meal glucose swings that insulin alone handles badly
  • โ€ข Modest weight loss is a welcome side effect for most people who need it
Cons
  • โ€ข Boxed warning for severe hypoglycaemia โ€” the mealtime insulin dose must be halved when starting
  • โ€ข Injected before every meal, on top of insulin, and never in the same syringe
  • โ€ข Nausea is common early and is the usual reason people stop
  • โ€ข Contraindicated in gastroparesis and in hypoglycaemia unawareness, which excludes many of the people who might want it
  • โ€ข Largely superseded for weight purposes by the weekly amylin analogs

When to stop

  • โ€ข Any severe hypoglycaemic episode, especially in the first weeks after starting
  • โ€ข Persistent vomiting or signs of gastroparesis
  • โ€ข You cannot reliably reduce and re-titrate mealtime insulin with a clinician
  • โ€ข You have lost the ability to recognise a low

Interactions

Mealtime insulinCaution

The boxed-warning interaction. Mealtime insulin is reduced by half when pramlintide is started, and titrated back under supervision. This is not optional.

Drugs that slow gastric emptying (anticholinergics, opioids)Avoid

Additive delay on top of a drug whose mechanism is already delayed emptying.

Oral medications needing rapid absorptionTiming

Labelling advises taking drugs that depend on fast absorption at least an hour before, or two hours after, pramlintide.

Other glucose-lowering drugsCaution

Additive hypoglycaemia risk.

Other amylin analogs (cagrilintide)Avoid

Same mechanism, duplicated.

Is this for you?

Probably worth reading further if
  • โ€ข People with insulin-treated diabetes whose post-meal glucose swings are not controlled by insulin alone, under a prescriber
  • โ€ข Anyone reading this to understand why the amylin pathway matters for the newer weight drugs
Skip it if
  • โ€ข You have hypoglycaemia unawareness
  • โ€ข You have gastroparesis
  • โ€ข Your A1C is above 9%
  • โ€ข You want it for weight loss without diabetes โ€” wrong tool, several injections a day, and a boxed warning designed for a different situation

The one number

67 indexed randomised-trial records, and a boxed warning for severe hypoglycaemia with insulin
Pepdex evidence index, PubMed; Am J Health Syst Pharm 2005 (PMID 16278328)

Sources for the claims above

Drug & supplement interactions

  • โš MUST reduce mealtime insulin by 50% on first dose to prevent severe hypoglycemia (boxed warning)
  • โš Drugs that delay gastric emptying (anticholinergics) compound the slowing effect
  • โš Oral medications requiring rapid absorption: dose 1 hour before pramlintide

Community patterns

Members only
Free, no account needed

New to Pramlintide (Symlin)? Grab the starter checklist.

Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.

No spam, and we never sell your email. Just the checklist. Email support@pepdex.co to opt out any time.

AI Coach, live sample
Member answer
is 250mcg of bpc enough for a knee injury?
For a knee, is the standard working dose and a solid place to start. The trick with BPC is consistency, give it weeks, not days. , run it , and don't drop below , results tend to fall off under that line. If nothing's moved by week 3, that's when earns its place.
how much bac water for a 10mg reta vial?
is the standard play for a 10 mg reta vial. That gives you , clean unit math across the whole titration: on a 100-unit insulin syringe. Run instead if you want fewer, more concentrated shots. Most people titrate up over , and that mix keeps the numbers cleanest.
what should i track on bloodwork for tirzepatide?
Lipid panel, ALT/AST (liver enzymes), and an A1C, baseline before you start then every 3 months. If you've got metabolic-syndrome history, add fasting glucose and insulin so you can actually watch insulin sensitivity improve. You don't need a big hormone panel for a GLP-1.

Numbers redacted in this preview. Members get the full answer, on their own stack.

Ask the Coach anything about Pramlintide (Symlin) or your own stack. This is it working.

Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.

Unlock the full Coach, from $4.99/week โ†’

Frequently asked

What is Pramlintide (Symlin)?+
Pramlintide (sold as Symlin) is the synthetic copy of amylin, a satiety hormone your pancreas releases alongside insulin. FDA-approved as a mealtime injection for diabetes. It's the predecessor to Cagrilintide, just shorter-acting and used differently.
Is Pramlintide (Symlin) FDA approved?+
Approved as Symlin (2005) as adjunct to mealtime insulin in T1D and T2D.
Is Pramlintide (Symlin) legal?+
Pramlintide (Symlin) is FDA-approved and legal to obtain by prescription in the US. Yes, endocrinology providers prescribe in insulin-using diabetes contexts.
Is Pramlintide (Symlin) banned by WADA?+
Pramlintide (Symlin) is not currently on the WADA prohibited list.
Are you still natty after taking Pramlintide (Symlin)?+
No. Pramlintide (Symlin) is a performance-enhancing peptide and would disqualify a strict natty claim.
Do doctors prescribe Pramlintide (Symlin)?+
Yes, endocrinology providers prescribe in insulin-using diabetes contexts.
What's the typical dose of Pramlintide (Symlin)?+
Dosing depends on your goal, experience, and tolerance. The full Pramlintide (Symlin) protocol (dose, frequency, and how to titrate) is in the members section on the entry page.
What are the side effects of Pramlintide (Symlin)?+
Common side effects include: Severe hypoglycemia (when paired with insulin without dose adjustment, boxed warning); Nausea, vomiting; Anorexia; Headache. Less common effects and full safety details are on the entry page.
How long until Pramlintide (Symlin) starts working?+
Post-meal glucose excursions reduce. Satiety improves.
What can you stack with Pramlintide (Symlin)?+
Pramlintide (Symlin) is commonly combined with complementary compounds. The full stacking protocol (what to pair, dosing, and timing) is in the members section on the entry page.
Where do people get Pramlintide (Symlin)?+
Pepdex does not sell, ship, or recommend suppliers. Pramlintide (Symlin) is FDA-approved and dispensed through licensed pharmacies with a prescription; some telehealth clinics prescribe it. If you're vetting a source, /coa explains how to verify a Certificate of Analysis.

Common questions about Pramlintide (Symlin)

Tracked alongside Pramlintide (Symlin)

Same goal, different aisle โ€” each graded on its own evidence in the Pepdex catalog.

Whey protein โ†’
muscle preservation is the open question on any GLP-1 run
Electrolytes โ†’
appetite suppression cuts fluid and sodium intake with it
Fiber โ†’
the constipation answer that shows up in every GLP-1 thread
Metformin โ†’
the prescription neighbour people compare these protocols against

More in Fat Loss

โ„– 009
Tirzepatide

Strong weight loss with a cleaner side effect profile than semaglutide. A dual agonist (GLP-1 + GIP), FDA-approved as Mounjaro / Zepbound.

โ„– 010
Semaglutide

The original weight-loss wave, sold as Ozempic / Wegovy. A GLP-1 agonist.

โ„– 003
Retatrutide

Triple agonist (GLP-1 + GIP + glucagon) from Eli Lilly. In trials it outperforms Tirzepatide for weight loss.

โ„– 059
Liraglutide (Saxenda / Victoza)

Daily GLP-1 receptor agonist. FDA-approved 2010 (Victoza, T2D) and 2014 (Saxenda, obesity). The first wave of modern GLP-1 weight-loss therapy and direct predecessor to Semaglutide.